Patents by Inventor Mark Cranfield

Mark Cranfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunological assay and antibodies for anti-mullerian hormone
    Patent number: 7897350
    Abstract: The present invention discloses compositions and methods to measure an amount of Anti-Mullerian Hormone (AMH) in a sample, including a mammalian sample such as a primate, rodent, equine, or bovine sample. The compositions and methods herein also provide antibodies that bind to epitopes on AMH that are stable to proteolysis of AMH.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: March 1, 2011
    Assignees: Beckman Coulter, Inc., Oxford Brookes University
    Inventors: Nigel Patrick Groome, Mark Cranfield, Axel P. N. Themmen, Gopal V. Savjani, Ketusha Mehta
  • Immunological assay and antibodies for Anti-Mullerian Hormone
    Publication number: 20060275850
    Abstract: The present invention discloses compositions and methods to measure an amount of Anti-Mullerian Hormone (AMH) in a sample, including a mammalian sample such as a primate, rodent, equine, or bovine sample. The compositions and methods herein also provide antibodies that bind to epitopes on AMH that are stable to proteolysis of AMH.
    Type: Application
    Filed: May 24, 2006
    Publication date: December 7, 2006
    Inventors: Nigel Groome, Mark Cranfield, Axel Themmen, Gopal Savjani, Ketusha Mehta
  • Method of diagnosis, treatment and useful agents for conditions characterised by modulation in the level of activin ssc
    Publication number: 20060172347
    Abstract: The present invention relates generally to a method of diagnosing, predicting or monitoring the development or progress of a condition characterised by modulation in the level of activin expression and, more particularly, a method of diagnosing, predicting or monitoring the development or progress of a condition characterised by modulation in the level of expression of activin bc subunit. The present invention still further provides methods for the therapeutic or prophylactic treatment of conditions characterised by aberrant, unwanted or otherwise inappropriate activin expression, for example, conditions characterised by over-expression or underexpression of activin and most particularly, conditions characterised by overexpression or underexpression of activin bc subunit. A further aspect of the present invention extends to agents for use in the methods of the present invention.
    Type: Application
    Filed: December 12, 2003
    Publication date: August 3, 2006
    Applicant: Monash University
    Inventors: Sally Mellor, Gail Risbridger, Emma Ball, Hong Wang, Catriona McClean, John Pedersen, Anne O'Connor, Mark Cranfield, Nigel Groome
  • Methods and compositions for modulating and detecting activin dimer and dimer formation
    Publication number: 20050266519
    Abstract: Methods and compositions for modulating activin dimer formation, such as the formation of activin dimers formed by the dimerisation of activin subunits ?A, ?B, ?C, ?D, or ?E, or combinations thereof, are provided. The invention also relates to methods and compositions for detecting an activin monomer or dimer using, for example, an antibody. Methods and compositions for diagnosing and/or prognosing, preventing or treating conditions and/or diseases associated with activin dimer formation, such as prostate cancer, are disclosed.
    Type: Application
    Filed: December 12, 2002
    Publication date: December 1, 2005
    Inventors: Sally Mellor, Gail Risbridger, Nigel Groome, Mark Cranfield, Emma Ball, Anne O'Connor, David Phillips, Jacqui Schmitt, Jean Ethier